168 related articles for article (PubMed ID: 19749756)
21. Role of interleukin-28B polymorphism as a predictor of sustained virological response in patients with chronic hepatitis C treated with triple therapy: a systematic review and meta-analysis.
Bota S; Sporea I; Şirli R; Neghină AM; Popescu A; Străin M
Clin Drug Investig; 2013 May; 33(5):325-31. PubMed ID: 23532802
[TBL] [Abstract][Full Text] [Related]
22. New genetic discoveries and treatment for hepatitis C.
Pacanowski M; Amur S; Zineh I
JAMA; 2012 May; 307(18):1921-2. PubMed ID: 22570460
[No Abstract] [Full Text] [Related]
23. Optimum ribavirin exposure overcomes racial disparity in efficacy of peginterferon and ribavirin treatment for hepatitis C genotype 1.
Jin R; Cai L; Tan M; McHutchison JG; Dowling TC; Howell CD
Am J Gastroenterol; 2012 Nov; 107(11):1675-83. PubMed ID: 23090351
[TBL] [Abstract][Full Text] [Related]
24. Roles of ITPA and IL28B genotypes in chronic hepatitis C patients treated with peginterferon plus ribavirin.
Miyamura T; Kanda T; Nakamoto S; Wu S; Jiang X; Arai M; Fujiwara K; Imazeki F; Yokosuka O
Viruses; 2012 Aug; 4(8):1264-78. PubMed ID: 23012624
[TBL] [Abstract][Full Text] [Related]
25. No association between the IL28B SNP and response to peginterferon plus ribavirin combination treatment in Korean chronic hepatitis C patients.
Heo NY; Lim YS; Lee W; Oh M; An J; Lee D; Shim JH; Kim KM; Lee HC; Lee YS; Suh DJ
Clin Mol Hepatol; 2014 Jun; 20(2):177-84. PubMed ID: 25032184
[TBL] [Abstract][Full Text] [Related]
26. Randomized trial of peginterferon α-2a plus ribavirin versus peginterferon α-2b plus ribavirin for chronic hepatitis C in Japanese patients.
Miyase S; Haraoka K; Ouchida Y; Morishita Y; Fujiyama S
J Gastroenterol; 2012 Sep; 47(9):1014-21. PubMed ID: 22382633
[TBL] [Abstract][Full Text] [Related]
27. Value of interleukin-28B genetic polymorphism on retreatment outcomes of chronic hepatitis C genotype 1 relapsers by peginterferon alfa plus ribavirin.
Chen MY; Liu CH; Chen TC; Su TH; Chen PJ; Chen DS; Kao JH; Liu CJ
J Gastroenterol Hepatol; 2014 Jan; 29(1):102-9. PubMed ID: 23829453
[TBL] [Abstract][Full Text] [Related]
28. Interferon-induced gene expression is a stronger predictor of treatment response than IL28B genotype in patients with hepatitis C.
Dill MT; Duong FH; Vogt JE; Bibert S; Bochud PY; Terracciano L; Papassotiropoulos A; Roth V; Heim MH
Gastroenterology; 2011 Mar; 140(3):1021-31. PubMed ID: 21111740
[TBL] [Abstract][Full Text] [Related]
29. Prediction of response to peginterferon-alfa-2b plus ribavirin therapy in Japanese patients infected with hepatitis C virus genotype 1b.
Hashimoto Y; Ochi H; Abe H; Hayashida Y; Tsuge M; Mitsui F; Hiraga N; Imamura M; Takahashi S; Nelson Hayes C; Ohishi W; Kubo M; Tsunoda T; Kamatani N; Nakamura Y; Chayama K
J Med Virol; 2011 Jun; 83(6):981-8. PubMed ID: 21503910
[TBL] [Abstract][Full Text] [Related]
30. A randomized phase 2b study of peginterferon lambda-1a for the treatment of chronic HCV infection.
Muir AJ; Arora S; Everson G; Flisiak R; George J; Ghalib R; Gordon SC; Gray T; Greenbloom S; Hassanein T; Hillson J; Horga MA; Jacobson IM; Jeffers L; Kowdley KV; Lawitz E; Lueth S; Rodriguez-Torres M; Rustgi V; Shemanski L; Shiffman ML; Srinivasan S; Vargas HE; Vierling JM; Xu D; Lopez-Talavera JC; Zeuzem S;
J Hepatol; 2014 Dec; 61(6):1238-46. PubMed ID: 25064437
[TBL] [Abstract][Full Text] [Related]
31. The genotype CC of IL-28B SNP rs12979860 is significantly associated with a sustained virological response in chronic HCV-infected Pakistani patients.
Khubaib B; Saleem S; Idrees M; Afzal S; Wasim M
J Dig Dis; 2015 May; 16(5):293-8. PubMed ID: 25708904
[TBL] [Abstract][Full Text] [Related]
32. IL28B and IL10R -1087 polymorphisms are protective for chronic genotype 1 HCV infection and predictors of response to interferon-based therapy in an East-Central European cohort.
Pár A; Pár G; Tornai I; Szalay F; Várszegi D; Fráter E; Papp M; Lengyel G; Fehér J; Varga M; Gervain J; Schuller J; Nemes Z; Péterfi Z; Tusnádi A; Hunyady B; Haragh A; Szinku Z; Vincze A; Szereday L; Kisfali P; Melegh B
BMC Res Notes; 2014 Jan; 7():12. PubMed ID: 24398031
[TBL] [Abstract][Full Text] [Related]
33. Impact of IL-28B polymorphisms on pegylated interferon plus ribavirin treatment response in children and adolescents infected with HCV genotypes 1 and 4.
Domagalski K; Pawłowska M; Tretyn A; Halota W; Pilarczyk M; Smukalska E; Linkowska K; Grzybowski T
Eur J Clin Microbiol Infect Dis; 2013 Jun; 32(6):745-54. PubMed ID: 23314745
[TBL] [Abstract][Full Text] [Related]
34. Interleukin-28B genetic variations and response to interferon-based therapy: Asian perspectives.
Liu CH; Kao JH
J Gastroenterol Hepatol; 2011 Sep; 26(9):1348-53. PubMed ID: 21884245
[No Abstract] [Full Text] [Related]
35. High resolution melting curve assay for detecting rs12979860 IL28B polymorphisms involved in response of Iranian patients to chronic hepatitis C treatment.
Fateh A; Aghasadeghi MR; Keyvani H; Mollaie HR; Yari S; Hadizade Tasbiti AR; Ghazanfari M; Monavari SH
Asian Pac J Cancer Prev; 2015; 16(5):1873-80. PubMed ID: 25773839
[TBL] [Abstract][Full Text] [Related]
36. Confounding by Single Nucleotide Polymorphism rs117648444 (P70S) Affects the Association of Interferon Lambda Locus Variants with Response to Interferon-α-Ribavirin Therapy in Patients with Chronic Genotype 3 Hepatitis C Virus Infection.
Bhushan A; Ghosh S; Bhattacharjee S; Chinnaswamy S
J Interferon Cytokine Res; 2017 Aug; 37(8):369-382. PubMed ID: 28727946
[TBL] [Abstract][Full Text] [Related]
37. Association between IL28B polymorphisms and first-phase viral load decrease in chronic hepatitis C virus-infected patients treated with peginterferon alfa-2b/ribavirin.
Arends JE; Fransen JH; Hoepelman AI; van Baarle D
Int J Antimicrob Agents; 2011 Dec; 38(6):538-9. PubMed ID: 21974859
[TBL] [Abstract][Full Text] [Related]
38. Antiviral combination therapy with peginterferon and ribavirin does not induce a therapeutically resistant mutation in the HCV core region regardless of genetic polymorphism near the IL28B gene.
Toyoda H; Kumada T; Hayashi K; Honda T; Katano Y; Goto H; Kawaguchi T; Murakami Y; Matsuda F
J Med Virol; 2011 Sep; 83(9):1559-64. PubMed ID: 21739446
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of peginterferon and ribavirin is associated with the IL28B gene in Korean patients with chronic hepatitis C.
Jeong SH; Jung YK; Yang JW; Park SJ; Kim JW; Kwon OS; Kim YS; Choi DJ; Kim JH
Clin Mol Hepatol; 2012 Dec; 18(4):360-7. PubMed ID: 23323251
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of
Świątek-Kościelna B; Kałużna E; Strauss E; Nowak J; Bereszyńska I; Gowin E; Wysocki J; Rembowska J; Barcińska D; Mozer-Lisewska I; Januszkiewicz-Lewandowska D
World J Gastroenterol; 2017 Jun; 23(21):3815-3824. PubMed ID: 28638221
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
